Last update 30 Oct 2025

Azilsartan Kamedoxomil/Amlodipine Besylate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Potassium Azilsartan Medoxomil/Amlodipine Besylate, Edardipine, 이달디핀정
Target
AT1R x L-type calcium channel
Action
antagonists, blockers
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), L-type calcium channel blockers(Voltage-gated L-type calcium channel blockers)
Therapeutic Areas
Cardiovascular Diseases
Active Indication
Essential Hypertension
Inactive Indication-
Originator Organization
Celltrion, Inc.Celltrion, Inc.
Active Organization
Celltrion, Inc.Celltrion, Inc.
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
South Korea (29 Oct 2025),
Essential Hypertension
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC20H25ClN2O5
InChIKeyHTIQEAQVCYTUBX-UHFFFAOYSA-N
CAS Registry88150-42-9
View All Structures (4)

Related

1
Clinical Trials associated with Azilsartan Kamedoxomil/Amlodipine Besylate
CTRI/2022/02/040081
/ CompletedPhase 3
ââ?¬Å?A Multicentric, Randomized, Double Blind, Parallel Group, Comparative, Phase III Clinical Study to Evaluate the Efficacy, Safety and Tolerability of FDC of Azilsartan Medoxomil 40 mg plus Amlodipine 5 mg Tablets and FDC of Azilsartan Medoxomil 80 mg plus Amlodipine 5 mg Tablets Versus FDC of Telmisartan 40 mg plus Amlodipine 5 mg Tablets in Patients with Stage 2 Hypertension.ââ?¬?
100 Clinical Results associated with Azilsartan Kamedoxomil/Amlodipine Besylate
Login to view more data
100 Translational Medicine associated with Azilsartan Kamedoxomil/Amlodipine Besylate
Login to view more data
100 Patents (Medical) associated with Azilsartan Kamedoxomil/Amlodipine Besylate
Login to view more data
100 Deals associated with Azilsartan Kamedoxomil/Amlodipine Besylate
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Essential Hypertension
South Korea
Celltrion, Inc.Celltrion, Inc.
29 Oct 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free